ONL Therapeutics' Debt Round

ONL Therapeutics raised a round of funding on August 10, 2016.

ONL Therapeutics is a biopharmaceutical company dedicated to protecting vision through the protection of photoreceptors. The current market for retinal drugs is greater than $7 billion and rapidly gro…

Articles about ONL Therapeutics' Debt Round: